Evidence map›Paper›PMID 25750247›Full record

ArticleSchizophrenia bulletin2015

Modeling determinants of medication attitudes and poor adherence in early nonaffective psychosis: implications for intervention.

Richard J Drake, Merete Nordentoft, Gillian Haddock, Celso Arango, W Wolfgang Fleischhacker, Birte Glenthøj, Marion Leboyer, Stefan Leucht, Markus Leweke, Phillip McGuire and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Schizophrenia bulletin, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Review
  6. Article
  7. Article
  8. Dynamics between insight and medication adherence in first-episode psychosis: Study of 3-year trajectories.European psychiatry : the journal of the Association of European Psychiatrists · 2022
    Article
  9. Article
  10. Article
  11. The association between insight and depressive symptoms in schizophrenia: Undirected and Bayesian network analyses.European psychiatry : the journal of the Association of European Psychiatrists · 2020
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Factors affecting medication adherence in children receiving outpatient pharmacotherapy and parental adherence.Journal of child and adolescent psychiatric nursing : official publication of the Association of Child and Adolescent Psychiatric Nurses, Inc · 2015
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 11 institutions in 7 countries.

Richard J DrakeManchester Academic Health Sciences Centre, Institute of Brain, Behaviour & Mental Health, University of Manchester, Manchester, UK; Manchester Academic Health Sciences Centre, Manchester Mental Health & Social Care NHS Trust, Manchester, UK; richard.drake@manchester.ac.uk.
Merete NordentoftMental Health Centre Copenhagen, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen NV, Denmark;
Gillian HaddockManchester Academic Health Sciences Centre, Manchester Mental Health & Social Care NHS Trust, Manchester, UK; Manchester Academic Health Sciences Centre, School of Psychological Sciences, University of Manchester, Manchester, UK;
Celso ArangoDepartment of Child and Adolescent Psychiatry, Hospital General Universitario Gregorio Marañón, CIBERSAM, IiSGM, School of Medicine, Universidad Complutense de Madrid, Madrid, Spain;
W Wolfgang FleischhackerDepartment of Psychiatry and Psychotherapy, Medical University Innsbruck, Innsbruck, Austria;
Birte GlenthøjCenter for Neuropsychiatric Schizophrenia Research and Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research, Psychiatric Hospital Center Glostrup, Faculty of Health and Medical Sciences, University of Copenhagen, Glostrup, Denmark;
Marion LeboyerINSERM U955, Laboratoire Psychopathologie et génétique des maladies mentales, et AP-HP, DHU Pe-PSY, Pole de Psychiatrie et d'addictologie des Hôpitaux Universitaires Henri Mondor, Université Paris-Est, Créteil, France;
Stefan LeuchtDepartment of Psychiatry and Psychotherapy, Technische Universität München, München, Germany;
Markus LewekeCentral Institute of Mental Health, Mannheim, Germany;
Phillip McGuireKing's College London, Institute of Psychiatry, London, UK;
Andreas Meyer-LindenbergCentral Institute of Mental Health, Mannheim, Germany;
Dan RujescuPsychiatry, Molecular and Clinical Neurobiology, Ludwig-Maximilians University, München, München, Germany; Department of Psychiatry, University of Halle, Halle, Germany;
Iris E SommerDepartment of Psychiatry, Brain Center Rudolf Magnus, UMC Utrecht, Utrecht, The Netherlands.
René S KahnDepartment of Psychiatry, Brain Center Rudolf Magnus, UMC Utrecht, Utrecht, The Netherlands.
Shon W LewisManchester Academic Health Sciences Centre, Institute of Brain, Behaviour & Mental Health, University of Manchester, Manchester, UK; Manchester Academic Health Sciences Centre, Manchester Mental Health & Social Care NHS Trust, Manchester, UK;
Central Institute of Mental Health · DEManchester Academic Health Science Centre · GBUniversity Medical Center Utrecht · NLUniversity of Copenhagen · DKCentro de Investigación Biomédica en Red de Salud Mental · ESInnsbruck Medical University · ATInserm · FRKing's College London · GBLudwig-Maximilians-Universität München · DETechnical University of Munich · DEUniversity of Manchester · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We aimed to design a multimodal intervention to improve adherence following first episode psychosis, consistent with current evidence. Existing literature identified medication attitudes, insight, and characteristics of support as important determinants of adherence to medication: we examined medication attitudes, self-esteem, and insight in an early psychosis cohort better to understand their relationships. Existing longitudinal data from 309 patients with early Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, nonaffective psychosis (83% first episode) were analyzed to test the hypothesis that medication attitudes, while meaningfully different from "insight," correlated with insight and self-esteem, and change in each influenced the others. Rosenberg Self-Esteem Scale, Birchwood Insight Scale, and Positive and Negative Syndrome Scale insight were assessed at presentation, after 6 weeks and 3 and 18 months. Drug Attitudes Inventory (DAI) and treatment satisfaction were rated from 6 weeks onward. Structural equation models of their relationships were compared. Insight measures' and DAI's predictive validity were compared against relapse, readmission, and remission. Analysis found five latent constructs best fitted the data: medication attitudes, self-esteem, accepting need for treatment, self-rated insight, and objective insight. All were related and each affected the others as it changed, except self-esteem and medication attitudes. Low self-reported insight at presentation predicted readmission. Good 6-week insight (unlike drug attitudes) predicted remission. Literature review and data modeling indicated that a multimodal intervention using motivational interviewing, online psychoeducation, and SMS text medication reminders to enhance adherence without damaging self-concept was feasible and appropriate.

Indexed as

Health Knowledge, Attitudes, PracticeSelf ConceptAdultAwarenessHumansLongitudinal StudiesMedication AdherenceModels, StatisticalPsychotic Disordersadherencefirst episodeinsightmHealthschizophreniaself-esteemweb-based

Identifiers

PMID25750247
PMCPMC4393703
OpenAlexW2127158799

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.